Latest Non-steroidal anti-inflammatory drugs Stories
NASHVILLE, Tenn., Jan. 20 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) has donated 15,000 vials of Caldolor® (ibuprofen) Injection, an intravenous form of ibuprofen, to Haitian relief effort. Caldolor is the first and only injectable product approved for the treatment of pain and reduction of fever in the United States. As health conditions in Haiti continue to deteriorate, Caldolor is expected to help those suffering from fever as a result of disease or...
NASHVILLE, Tenn., Jan. 5 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that data from clinical trials for Caldolor® (ibuprofen) Injection, an intravenous formulation of ibuprofen approved to treat pain and fever in adults, will be presented at a Breakfast Satellite Symposium on Tuesday, January 12, 2010 from 6:30 to 8:00 am ET. The symposium, entitled "New Advances in the Management of Pain and Fever in the Hospital Setting," will be held at the...
A new study conducted at Ben-Gurion University of the Negev (BGU) reveals that Celebrex and other anti-inflammatory coxib medications may counter the positive effects of aspirin in preventing blood clots.The research, published in the Proceedings of the National Academy of Sciences (PNAS), indicates that people who are taking aspirin and coxibs together are in fact inhibiting the aspirin's effectiveness in preventing heart attacks and strokes."This finding strongly suggests that humans...
A new French study suggests that baby aspirin taken for high-risk pregnancy complications does not appear to harm brain development among very premature children assessed when 5 years old, but may even have some benefit, Reuters reported.Dr. Stephane Marret from Rouen University Hospital said it is necessary to confirm their data in other studies.He warned that physicians and pregnant women must always appreciate the potential impact on the developing baby of medications given to mothers...
IRVINE, Calif., Dec. 17 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced the Company submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for bromfenac ophthalmic solution dosed once-daily as a treatment for ocular inflammation and pain following cataract surgery. ISTA currently markets Xibrom(TM) (bromfenac ophthalmic solution) 0.09%, which is an eye drop labeled for use twice-daily, beginning 24 hours...
Athletes' superstitions and rituals can help them get psyched up for contests, but when these rituals involve non-steroidal anti-inflammatory drugs (NSAIDs), which many athletes gobble down before and during events, they could be causing more harm than good."These agents are treatments for the symptoms of an injury, not the injury itself," says Stuart Warden, whose research at Indiana University focuses on musculoskeletal health and sports medicine. "They may allow an athlete...
Combining celebrex with low-dose aspirin may reduce protection from heart attack and stroke, study suggestsMillions of Americans take Celebrex for arthritis or other pain. Many, if they are middle-aged or older, also take a low-dose aspirin tablet daily to reduce the risk of heart attack and stroke. Yet they may be getting little protection, because Celebrex keeps the aspirin from doing its job effectively, a new study suggests.In laboratory studies, University of Michigan researchers found...
A second veterinary pain drug used to treat cattle could be deadly to endangered vultures that feed on the carcasses of livestock, according to a study released Wednesday.The death toll of the slender-billed and oriental white-backed vultures has reached the millions in South Asia, mostly in India, after consuming the carcasses of sick cattle that had been treated with anti-inflammatory painkiller diclofenac, reported the Associated Press.Researchers writing in the Royal Society journal...
Nashville, Tenn., Dec. 9 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced that it has entered into an exclusive agreement with DB Pharm Korea Co. Ltd., a Korean-based pharmaceutical company, for the commercialization of Caldolor® (ibuprofen) Injection in South Korea. Designed to treat pain and fever in the hospital setting, Caldolor was approved by the U.S. Food and Drug Administration and launched by Cumberland in the United States earlier this...
NASHVILLE, Tenn., Dec. 3 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that data from a recent clinical trial for Caldolor® (ibuprofen) Injection, an intravenous treatment for pain and fever, will be presented at the 44th American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting in Las Vegas, Nevada, in December. The new data will be displayed in a poster presentation on Monday, December 7, from 2:30 to 5:00 pm PST (board...
